These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21575312)

  • 21. TIMEBOMB revisited 10 years later: can we sustain progress or are we losing the war?
    Reichman LB
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1377-82. PubMed ID: 24125437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDR-TB in Eastern Europe in the era of the TB elimination action framework.
    Dudnyk A; Butov D; Crudu V; Lange C; Chesov D
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):2-3. PubMed ID: 28157456
    [No Abstract]   [Full Text] [Related]  

  • 23. [New antitubercular agents are not where where we need them to be].
    Nau JY
    Rev Med Suisse; 2015 Dec; 11(499):2408-9. PubMed ID: 26852561
    [No Abstract]   [Full Text] [Related]  

  • 24. Multidrug-resistant tuberculosis management in resource-limited settings.
    Nathanson E; Lambregts-van Weezenbeek C; Rich ML; Gupta R; Bayona J; Blöndal K; Caminero JA; Cegielski JP; Danilovits M; Espinal MA; Hollo V; Jaramillo E; Leimane V; Mitnick CD; Mukherjee JS; Nunn P; Pasechnikov A; Tupasi T; Wells C; Raviglione MC
    Emerg Infect Dis; 2006 Sep; 12(9):1389-97. PubMed ID: 17073088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Nourzad S; Jenkins HE; Milstein M; Mitnick CD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam.
    Hoa NB; Khanh PH; Chinh NV; Hennig CM
    Trop Med Int Health; 2014 Sep; 19(9):1076-81. PubMed ID: 24995611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment.
    Hwang TJ; Keshavjee S
    PLoS Med; 2014 Sep; 11(9):e1001738. PubMed ID: 25268235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gains in tuberculosis control at risk due to 3 million missed patients and drug resistance. Progress in TB control can be substantially accelerated by addressing these challenges.
    Cent Eur J Public Health; 2013 Dec; 21(4):236-7. PubMed ID: 24592733
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-Resistant tuberculosis - primary transmission and management.
    Outhred AC; Britton PN; Marais BJ
    J Infect; 2017 Jun; 74 Suppl 1():S128-S135. PubMed ID: 28646952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carpe diem ('Seize the day'): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa.
    Loveday M; Cox H
    S Afr Med J; 2017 Feb; 107(3):176-177. PubMed ID: 28281418
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Garrido Mda S; Bührer-Sékula S; Souza AB; de Oliveira GP; Antunes IA; Mendes JM; Saraceni V; Martinez-Espinosa FE; Ramasawmy R
    Int J Tuberc Lung Dis; 2015 May; 19(5):531-6. PubMed ID: 25868020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress towards TB reduction targets is faltering, report finds.
    Cousins S
    BMJ; 2017 Oct; 359():j4758. PubMed ID: 29030533
    [No Abstract]   [Full Text] [Related]  

  • 36. Certification of TB culture and drug susceptibility testing laboratories through the Revised National Tuberculosis Control Programme (RNTCP).
    Sachdeva KS; Nagaraja SB; Kumar A; Kumar P; Ramachandran R
    J Indian Med Assoc; 2012 Jul; 110(7):488-9. PubMed ID: 23520677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Guglielmetti L; Hewison C; Avaliani Z; Hughes J; Kiria N; Lomtadze N; Ndjeka N; Setkina S; Shabangu A; Sikhondze W; Skrahina A; Veziris N; Furin J
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):167-174. PubMed ID: 28234080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug resistance in new tuberculosis patients: burden and implications.
    Royce S; Falzon D; van Weezenbeek C; Dara M; Hyder K; Hopewell P; Richardson MD; Zignol M
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):511-3. PubMed ID: 23485384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.